Kerry Clem
2022
In 2022, Kerry Clem earned a total compensation of $592.2K as Chief Commercial Officer at Acorda Therapeutics, a 11% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $168,075 |
|---|---|
| Salary | $415,000 |
| Other | $9,150 |
| Total | $592,225 |
Clem received $415K in salary, accounting for 70% of the total pay in 2022.
Clem also received $168.1K in non-equity incentive plan and $9.2K in other compensation.
Rankings
In 2022, Kerry Clem's compensation ranked 4,090th out of 5,760 executives tracked by ExecPay. In other words, Clem earned more than 29.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,090 out of 5,760 | 29th |
Division Manufacturing | 2,309 out of 3,136 | 26th |
Major group Chemicals And Allied Products | 1,120 out of 1,422 | 21st |
Industry group Drugs | 1,051 out of 1,323 | 21st |
Industry Biological Products, Except Diagnostic Substances | 247 out of 291 | 15th |
Pay ratio
| Kerry Clem's Pay | $592,225 |
|---|---|
| Median Employee's Pay | $218,380 |
| Pay Ratio | 3to 1 |
In 2022, the annual total compensation of Kerry Clem was $592,225.
The annual total compensation of the median employee at Acorda Therapeutics was $218,380.
The ratio of Kerry Clem's pay to the pay of median employee was therefore 3 to one.
Source: SEC filing on April 27, 2023.
Clem's colleagues
We found three more compensation records of executives who worked with Kerry Clem at Acorda Therapeutics in 2022.